Market capitalization | AUD17.29b |
Enterprise Value | AUD17.15b |
P/E (TTM) P/E ratio | 46.83 |
EV/FCF (TTM) EV/FCF | 62.43 |
EV/Sales (TTM) EV/Sales | 7.41 |
P/S ratio (TTM) P/S ratio | 7.47 |
P/B ratio (TTM) P/B ratio | 9.26 |
Dividend yield | 1.55% |
Last dividend (FY24) | AUD4.10 |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
18 Analysts have issued a Cochlear forecast:
18 Analysts have issued a Cochlear forecast:
Dec '24 |
+/-
%
|
||
Revenue | 2,315 2,315 |
6%
6%
|
|
Gross Profit | 1,741 1,741 |
7%
7%
|
|
EBITDA | 597 597 |
4%
4%
|
EBIT (Operating Income) EBIT | 511 511 |
5%
5%
|
Net Profit | 371 371 |
6%
6%
|
In millions AUD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
Head office | Australia |
CEO | Diggory Howitt |
Employees | 5,000 |
Founded | 1983 |
Website | www.cochlear.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.